Berro joined Roche in 2003 and assumed her current position in 2019. In 2021, Roche signed an MoU with Microsoft to leverage AI and cloud computing in diagnosis across the Middle East. The company’s pharmaceuticals division reported global sales of $47 billion in 2021. In September 2022, Berro helped to launch RISE, a talent development program. In 2022, she oversaw an agreement with the King Faisal Specialist Hospital and Research Centre in Riyadh. Berro is also a member of the Executive Committee of the PhRMA Middle East & Africa, the regional arm of the Pharmaceutical Research & Manufacturers of America, and Roche’s Diversity and Inclusion Council.